The effect of NADPH oxidase inhibitor apocynin in treatment of diabetic nephropathy.

被引:0
|
作者
Jiang, ZP [1 ]
Peng, YQ [1 ]
Ji, YL [1 ]
Yu, XQ [1 ]
机构
[1] Zhongshan Univ, Dept Nephrol, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:404A / 404A
页数:1
相关论文
共 50 条
  • [21] The NADPH Oxidase Inhibitor Apocynin Suppresses Preneoplastic Liver Foci of Rats
    Fuji, Satoshi
    Suzuki, Shugo
    Naiki-Ito, Aya
    Kato, Hiroyuki
    Hayakawa, Masashi
    Yamashita, Yoriko
    Kuno, Toshiya
    Takahashi, Satoru
    TOXICOLOGIC PATHOLOGY, 2017, 45 (04) : 544 - 550
  • [22] Treatment of hypertension in diabetic patients with nephropathy.
    Komers R.
    Anderson S.
    Current Diabetes Reports, 2001, 1 (3) : 251 - 260
  • [23] DELETERIOUS EFFECT OF NADPH OXIDASE-NOX5 IN DIABETIC NEPHROPATHY
    Jha, J. C.
    Gray, S. P.
    Banal, C.
    Schmidt, H. H. H. W.
    Cooper, M. E.
    Touyz, R. M.
    Kennedy, C. R. J.
    Jandeleit-Dahm, K. A.
    NEPHROLOGY, 2015, 20 : 23 - 24
  • [24] Re-engineering a natural product, apocynin, into an NADPH oxidase inhibitor
    Senevirathne, Priyangika
    Zhu, Haizhou
    Edward, Merino
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [25] Effect of the NADPH oxidase inhibitor apocynin on ischemia-reperfusion hippocampus injury in rat brain
    Kapoor, Monika
    Sharma, Neha
    Sandhir, Rajat
    Nehru, Bimla
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 97 : 458 - 472
  • [26] Diabetic nephropathy. Current diagnostics and treatment
    Werth, S.
    Lehnert, H.
    Steinhoff, J.
    INTERNIST, 2015, 56 (05): : 513 - 519
  • [27] Diabetic nephropathy.
    Hasslacher, C.
    Wolf, G.
    Kempe, P.
    Ritz, E.
    DIABETOLOGIE UND STOFFWECHSEL, 2010, 5 : S113 - S116
  • [28] Effect of glucosaminoglycans in children with diabetic nephropathy.
    Mishina, II
    Scherbacheva, LN
    Peterkova, VA
    DIABETOLOGIA, 1998, 41 : A285 - A285
  • [29] NADPH oxidase inhibitor, apocynin, improves renal glutathione status in Zucker diabetic fatty rats: A comparison with melatonin
    Winiarska, Katarzyna
    Focht, Dorota
    Sierakowski, Bartosz
    Lewandowski, Krystian
    Orlowska, Marta
    Usarek, Michal
    CHEMICO-BIOLOGICAL INTERACTIONS, 2014, 218 : 12 - 19
  • [30] The role of the methoxyphenol apocynin, a vascular NADPH oxidase inhibitor, as a chemopreventative agent in the potential treatment of cardiovascular diseases
    Yu, Jingjing
    Weiwer, Michel
    Linhardt, Robert J.
    Dordick, Jonathan S.
    CURRENT VASCULAR PHARMACOLOGY, 2008, 6 (03) : 204 - 217